MA42317B2 - Composition de vaccin combinée pour administration multiple - Google Patents

Composition de vaccin combinée pour administration multiple

Info

Publication number
MA42317B2
MA42317B2 MA42317A MA42317A MA42317B2 MA 42317 B2 MA42317 B2 MA 42317B2 MA 42317 A MA42317 A MA 42317A MA 42317 A MA42317 A MA 42317A MA 42317 B2 MA42317 B2 MA 42317B2
Authority
MA
Morocco
Prior art keywords
vaccine
combination vaccine
vaccine composition
multiple administration
immunogenic composition
Prior art date
Application number
MA42317A
Other languages
English (en)
Inventor
Suk Young Choi
Yoon Ae Noh
Eun Ji Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MA42317B2 publication Critical patent/MA42317B2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A61K31/115—Formaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition immunogène à doses multiples pour un vaccin combiné multivalent, dans laquelle (i) le vaccin combiné multivalent contient un vaccin contre la coqueluche vaccin à cellules entières (wp) ou un vaccin contre la coqueluche acellulaire(ap), et un vaccin contre la polio inactivé sabin (sipv) ; et (ii) la composition contient du 2-phénoxyéthanol (2-pe) et du formaldéhyde (hcho) en tant que conservateurs ; et un procédé de préparation d'une composition immunogène à d
MA42317A 2015-09-16 2016-09-13 Composition de vaccin combinée pour administration multiple MA42317B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150131157 2015-09-16
PCT/KR2016/010313 WO2017048038A1 (fr) 2015-09-16 2016-09-13 Composition de vaccin combinée pour administration multiple

Publications (1)

Publication Number Publication Date
MA42317B2 true MA42317B2 (fr) 2021-11-30

Family

ID=58289554

Family Applications (2)

Application Number Title Priority Date Filing Date
MA42317A MA42317B2 (fr) 2015-09-16 2016-09-13 Composition de vaccin combinée pour administration multiple
MA52400A MA52400B1 (fr) 2015-09-16 2016-09-13 Composition de vaccin combinée pour administration multiple

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA52400A MA52400B1 (fr) 2015-09-16 2016-09-13 Composition de vaccin combinée pour administration multiple

Country Status (7)

Country Link
KR (1) KR101864029B1 (fr)
BR (1) BR112018005291A2 (fr)
EA (1) EA037283B1 (fr)
MA (2) MA42317B2 (fr)
PH (1) PH12018500570A1 (fr)
TN (1) TN2018000063A1 (fr)
WO (1) WO2017048038A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018169303A1 (fr) * 2017-03-15 2018-09-20 주식회사 엘지화학 Composition vaccinale polyvalente contre streptococcus pneumoniae
BR112020000999A2 (pt) * 2017-07-18 2020-07-14 Serum Institute Of India Pvt Ltd. composição imunogênica tendo estabilidade aperfeiçoada, imunogenicidade melhorada e reatogenicidade reduzida e processo para a sua preparação
CA3115803A1 (fr) * 2018-10-12 2020-04-16 Serum Institute Of India Private Ltd. Composition vaccinale combinee comprenant un poliovirus inactive a dose reduite et son procede de preparation
WO2021176409A1 (fr) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Combinaison de conservateurs pour composition de vaccin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920009729B1 (ko) * 1990-08-29 1992-10-22 주식회사 녹십자 백일해, 디프테리아, 파상풍 및 b형 간염의 동시 예방을 위한 혼합백신
KR920009729A (ko) * 1990-11-26 1992-06-25 전금자 원적외선이 발생하는 도자기 제조방법
DE69319728T2 (de) * 1992-05-23 1999-02-04 Smithkline Beecham Biologicals S.A., Rixensart Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
EP2505192B1 (fr) * 2007-09-12 2016-05-04 Galderma Research & Development Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
PE20100365A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
US20140112950A1 (en) * 2011-03-02 2014-04-24 Manmohan Singh Combination vaccines with lower doses of antigen and/or adjuvant

Also Published As

Publication number Publication date
KR101864029B1 (ko) 2018-06-01
WO2017048038A1 (fr) 2017-03-23
MA52400A1 (fr) 2022-06-30
KR20170033254A (ko) 2017-03-24
MA52400B1 (fr) 2023-01-31
PH12018500570A1 (en) 2018-09-17
EA037283B1 (ru) 2021-03-04
EA201890502A1 (ru) 2018-08-31
TN2018000063A1 (en) 2019-07-08
BR112018005291A2 (pt) 2018-10-09

Similar Documents

Publication Publication Date Title
MX2018002728A (es) Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas.
MX2021008224A (es) Combinacion de vacunacion e inhibicion de la trayectoria pd-1.
MX2015011478A (es) Compuestos de amida para el tratamiento de vih.
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
BR112018008078A2 (pt) vacina de vírus influenza de amplo espectro
AR108829A1 (es) Vacuna contra virus de bronquitis infecciosa
GB201101665D0 (en) Immunogenic compositions
CL2016003048A1 (es) Analogos de panonina minimas sintesis y uso de los mismos.
PH12013502442A1 (en) Inactivated dengue virus vaccine
MX2017012220A (es) Composiciones adyuvantes y metodos relacionados.
BR112015021523A2 (pt) composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa
EA202190778A1 (ru) Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
BR112013017171A2 (pt) vacina de combinação imunogênica estável, processo de preparação de vacina de combinação estável, método de uso de moléculas antigênicas e método de administração a indivíduos humanos
BR112019003992A2 (pt) vacina contra neisseria meningitidis
CL2015001329A1 (es) Composición para tratamiento por inmersion de raices de plantas.
BR112017006085A2 (pt) compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrm
MX2017000154A (es) Sistema de rinovacunacion de la vacuna contra la influenza.
MA52400A1 (fr) Composition de vaccin combinée pour administration multiple
MX2021012201A (es) Adyuvante soluble en agua.
AR117191A1 (es) Composiciones inmunogénicas
BR112018007673A2 (pt) ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos?
MX2017006744A (es) Composiciones adyuvantes y metodos relacionados.
BR112022020100A2 (pt) Vacina inativada contra vírus sars-cov-2